40 likes | 54 Views
The Ventilator Associated Pneumonia Market, on the basis of end users, is segmented into hospitals, research centers and clinics. Hospital segment dominates the global market owing rising incidence of pneumonia and need for immediate medical assistance. Ventilator-associated pneumonia (VAP) is a type of pneumonia that happens after endotracheal incubation, featured by the presence of a new or progressive virus. VAP is predicted to occur in quarter of all mechanically ventilated patients along with higher risk of being early in course of hospitalization. Risk for VAP is greatest during the first initial days of mechanical ventilation between the intubation and development of VAP. In the recent years, the accumulated risk of death has decreased and is more recently estimated at a significant percentage.
E N D
Ventilator Associated Pneumonia Market In-Depth Analysis by Types, Applications and Manufacturers till 2025 “Ventilator-associated pneumonia (VAP) is a type of pneumonia that happens after endotracheal incubation, featured by the presence of a new or progressive virus. VAP is a serious complication of mechanical ventilation which increases the patient’s stay in ICU and overall length of hospital incurs additional costs and is a most common of all nosocomial infections contributing to death.” The Ventilator Associated Pneumonia Market, on the basis of end users, is segmented into hospitals, research centers and clinics. Hospital segment dominates the global market owing rising incidence of pneumonia and need for immediate medical assistance. Ventilator-associated pneumonia (VAP) is a type of pneumonia that happens after endotracheal incubation, featured by the presence of a new or progressive virus. VAP is predicted to occur in quarter of all mechanically ventilated patients along with higher risk of being early in course of hospitalization. Risk for VAP is greatest during the first initial days of mechanical ventilation between the intubation and development of VAP. In the recent years, the accumulated risk of death has decreased and is more recently estimated at a significant percentage. VAP is a serious complication of mechanical ventilation which increases the patient’s stay in ICU and overall length of hospital incurs additional costs and is a most common of all nosocomial infections contributing to death. The risk factor is the endotracheal tube as mechanical ventilator support cannot be performed without the endotracheal tube. The endotracheal tube provides a direct passageway into the lungs, that bypasses natural protection mechanisms. Hence, the endotracheal tube augments the risk for VAP by; preventing cough, preventing upper airway filtering, preventing upper airway humidification, having a cuff that provides a place for secretions to pool in the hypoglottic area. Browse Full Research Report @ https://www.millioninsights.com/industry-reports/ventilator-associated-pneumonia-vap-market
The key driving factors responsible for the growth of ventilator associated pneumonia market includes growth in geriatric population and rising number of pneumonic patients especially in the cold countries. Additionally, government funding to eradicate lack of medical infrastructure for sparsely populated areas is also contributing to the growth of ventilator associated pneumonia market. On the basis of diagnosis types, the ventilator associated pneumonia market is segmented into clinical, radiological and microbiological. Clinical segment dominated the global ventilator associated pneumonia market owing to growth in number of pneumonic patients. On the basis of geographic segmentation, the global associated ventilator pneumonia market spans North America, Europe, China, Southeast Asia, Japan and India. North America dominates the global market due to growth in increasing rates of pneumonias. Europe is the second large market for ventilator-associated pneumonia (VAP) and is witnessed a higher CAGR during the assessment period. APAC regions also witnessed a higher CAGR growth during the assessment period. The key players in the global ventilator associated pneumonia market include Philips Respironics, Tyco, Hoffrichter, ResMed, Teleflex, Weinmann, Fisher & Paykel, and SYSMED. This report studies Ventilator Associated Pneumonia (VAP) in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021. Get a Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/ventilator-associated-pneumonia-vap-market/request-sample Market Segment: This report studies the global Ventilator Associated Pneumonia (VAP) market, analyzes and researches the Ventilator Associated Pneumonia (VAP) development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like • Philips Respironics • Hoffrichter • Tyco • Teleflex • Weinmann • ResMed • SYSMED • Fisher & Paykel Market segment by Regions/Countries, this report covers • United States
• EU • Japan • China • India • Southeast Asia See More Reports of This Category by Million Insights @ https://www.millioninsights.com/industry/medical-devices Market segment by Type, the product can be split into • Prevention • Physiotherapy • Immunity Therapy Market segment by Application, Ventilator Associated Pneumonia (VAP) can be split into • Hospitals • ASCs • Diagnostic Centers Browse Full Research Report @ https://www.millioninsights.com/industry-reports/ventilator-associated-pneumonia-vap-market
Get in touch At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions. Contact Person: Ryan Manuel Research Support Specialist, USA Email: ryan@millioninsights.com Global Headquarters Asia Pacific Million Insights Million Insights Felton Office Plaza 6265 Highway 9 Felton, California 95018, United States Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016 India Phone: 1-408-610-2300 Email: sales@millioninsights.com Phone: 91-20-65300184 Email: sales@millioninsights.com Visit Our Blog: www.millioninsights.blogspot.com